Cargando…

3-Methylcholanthrene Induces Chylous Ascites in TCDD-Inducible Poly-ADP-Ribose Polymerase (Tiparp) Knockout Mice

TCDD-inducible poly-ADP-ribose polymerase (TIPARP) is an aryl hydrocarbon receptor (AHR) target gene that functions as part of a negative feedback loop to repress AHR activity. Tiparp(−/−) mice exhibit increased sensitivity to the toxicological effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD),...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Tiffany E., Bott, Debbie, Ahmed, Shaimaa, Hutin, David, Gomez, Alvin, Tamblyn, Laura, Zhou, Angela C., Watts, Tania H., Grant, Denis M., Matthews, Jason
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540065/
https://www.ncbi.nlm.nih.gov/pubmed/31083300
http://dx.doi.org/10.3390/ijms20092312
_version_ 1783422537461399552
author Cho, Tiffany E.
Bott, Debbie
Ahmed, Shaimaa
Hutin, David
Gomez, Alvin
Tamblyn, Laura
Zhou, Angela C.
Watts, Tania H.
Grant, Denis M.
Matthews, Jason
author_facet Cho, Tiffany E.
Bott, Debbie
Ahmed, Shaimaa
Hutin, David
Gomez, Alvin
Tamblyn, Laura
Zhou, Angela C.
Watts, Tania H.
Grant, Denis M.
Matthews, Jason
author_sort Cho, Tiffany E.
collection PubMed
description TCDD-inducible poly-ADP-ribose polymerase (TIPARP) is an aryl hydrocarbon receptor (AHR) target gene that functions as part of a negative feedback loop to repress AHR activity. Tiparp(−/−) mice exhibit increased sensitivity to the toxicological effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), including lethal wasting syndrome. However, it is not known whether Tiparp(−/−) mice also exhibit increased sensitivity to other AHR ligands. In this study, we treated male Tiparp(−/−) or wild type (WT) mice with a single injection of 100 mg/kg 3-methylcholanthrene (3MC). Consistent with TIPARP’s role as a repressor of AHR signaling, 3MC-treated Tiparp(−/−) mice exhibited increased hepatic Cyp1a1 and Cyp1b1 levels compared with WT mice. No 3MC-treated Tiparp(−/−) mice survived beyond day 16 and the mice exhibited chylous ascites characterized by an accumulation of fluid in the peritoneal cavity. All WT mice survived the 30-day treatment and showed no signs of fluid accumulation. Treated Tiparp(−/−) mice also exhibited a transient and mild hepatotoxicity with inflammation. 3MC-treated WT, but not Tiparp(−/−) mice, developed mild hepatic steatosis. Lipid deposits accumulated on the surface of the liver and other abdominal organs in the 3MC-Tiparp(−/−) mice. Our study reveals that Tiparp(−/−) mice have increased sensitivity to 3MC-induced liver toxicity, but unlike with TCDD, lethality is due to chylous ascites rather than wasting syndrome.
format Online
Article
Text
id pubmed-6540065
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-65400652019-06-04 3-Methylcholanthrene Induces Chylous Ascites in TCDD-Inducible Poly-ADP-Ribose Polymerase (Tiparp) Knockout Mice Cho, Tiffany E. Bott, Debbie Ahmed, Shaimaa Hutin, David Gomez, Alvin Tamblyn, Laura Zhou, Angela C. Watts, Tania H. Grant, Denis M. Matthews, Jason Int J Mol Sci Article TCDD-inducible poly-ADP-ribose polymerase (TIPARP) is an aryl hydrocarbon receptor (AHR) target gene that functions as part of a negative feedback loop to repress AHR activity. Tiparp(−/−) mice exhibit increased sensitivity to the toxicological effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), including lethal wasting syndrome. However, it is not known whether Tiparp(−/−) mice also exhibit increased sensitivity to other AHR ligands. In this study, we treated male Tiparp(−/−) or wild type (WT) mice with a single injection of 100 mg/kg 3-methylcholanthrene (3MC). Consistent with TIPARP’s role as a repressor of AHR signaling, 3MC-treated Tiparp(−/−) mice exhibited increased hepatic Cyp1a1 and Cyp1b1 levels compared with WT mice. No 3MC-treated Tiparp(−/−) mice survived beyond day 16 and the mice exhibited chylous ascites characterized by an accumulation of fluid in the peritoneal cavity. All WT mice survived the 30-day treatment and showed no signs of fluid accumulation. Treated Tiparp(−/−) mice also exhibited a transient and mild hepatotoxicity with inflammation. 3MC-treated WT, but not Tiparp(−/−) mice, developed mild hepatic steatosis. Lipid deposits accumulated on the surface of the liver and other abdominal organs in the 3MC-Tiparp(−/−) mice. Our study reveals that Tiparp(−/−) mice have increased sensitivity to 3MC-induced liver toxicity, but unlike with TCDD, lethality is due to chylous ascites rather than wasting syndrome. MDPI 2019-05-10 /pmc/articles/PMC6540065/ /pubmed/31083300 http://dx.doi.org/10.3390/ijms20092312 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Cho, Tiffany E.
Bott, Debbie
Ahmed, Shaimaa
Hutin, David
Gomez, Alvin
Tamblyn, Laura
Zhou, Angela C.
Watts, Tania H.
Grant, Denis M.
Matthews, Jason
3-Methylcholanthrene Induces Chylous Ascites in TCDD-Inducible Poly-ADP-Ribose Polymerase (Tiparp) Knockout Mice
title 3-Methylcholanthrene Induces Chylous Ascites in TCDD-Inducible Poly-ADP-Ribose Polymerase (Tiparp) Knockout Mice
title_full 3-Methylcholanthrene Induces Chylous Ascites in TCDD-Inducible Poly-ADP-Ribose Polymerase (Tiparp) Knockout Mice
title_fullStr 3-Methylcholanthrene Induces Chylous Ascites in TCDD-Inducible Poly-ADP-Ribose Polymerase (Tiparp) Knockout Mice
title_full_unstemmed 3-Methylcholanthrene Induces Chylous Ascites in TCDD-Inducible Poly-ADP-Ribose Polymerase (Tiparp) Knockout Mice
title_short 3-Methylcholanthrene Induces Chylous Ascites in TCDD-Inducible Poly-ADP-Ribose Polymerase (Tiparp) Knockout Mice
title_sort 3-methylcholanthrene induces chylous ascites in tcdd-inducible poly-adp-ribose polymerase (tiparp) knockout mice
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540065/
https://www.ncbi.nlm.nih.gov/pubmed/31083300
http://dx.doi.org/10.3390/ijms20092312
work_keys_str_mv AT chotiffanye 3methylcholanthreneinduceschylousascitesintcddinduciblepolyadpribosepolymerasetiparpknockoutmice
AT bottdebbie 3methylcholanthreneinduceschylousascitesintcddinduciblepolyadpribosepolymerasetiparpknockoutmice
AT ahmedshaimaa 3methylcholanthreneinduceschylousascitesintcddinduciblepolyadpribosepolymerasetiparpknockoutmice
AT hutindavid 3methylcholanthreneinduceschylousascitesintcddinduciblepolyadpribosepolymerasetiparpknockoutmice
AT gomezalvin 3methylcholanthreneinduceschylousascitesintcddinduciblepolyadpribosepolymerasetiparpknockoutmice
AT tamblynlaura 3methylcholanthreneinduceschylousascitesintcddinduciblepolyadpribosepolymerasetiparpknockoutmice
AT zhouangelac 3methylcholanthreneinduceschylousascitesintcddinduciblepolyadpribosepolymerasetiparpknockoutmice
AT wattstaniah 3methylcholanthreneinduceschylousascitesintcddinduciblepolyadpribosepolymerasetiparpknockoutmice
AT grantdenism 3methylcholanthreneinduceschylousascitesintcddinduciblepolyadpribosepolymerasetiparpknockoutmice
AT matthewsjason 3methylcholanthreneinduceschylousascitesintcddinduciblepolyadpribosepolymerasetiparpknockoutmice